Sun Pharmaceutical Industries Share Price Today - Live Blog for July 07, 2025

Following a noteworthy 0.10% increase, Sun Pharmaceutical Industries Ltd's shares are now trading at ₹1,681.15. When it comes to valuation, this stock has a PE ratio of 36.8100, with the industry PE ratio at 35.3587.

In the financial arena, Sun Pharmaceutical Industries Ltd's stock price has increased by 0.10%, with its current market value per share resting at ₹1,681.30. This development highlights the stock's appeal to investors.

In the financial arena, Sun Pharmaceutical Industries Ltd's stock price has increased by 0.22%, with its current market value per share resting at ₹1,679.00. This development highlights the stock's appeal to investors.

Sun Pharmaceutical Industries Ltd shares saw a -0.04% decrease, reaching a current market price of ₹1,675.30. Investors are keeping a close watch on this development, looking for potential signals of a turnaround. The stock has a PE ratio of 36.8100, an ROE of 15.1334% and a debt to equity ratio of 0.0327.

Sun Pharmaceutical Industries Ltd's stock has risen by a substantial 0.14%, and as of now, it's trading at ₹1,676.80 per share. This upward trajectory is attracting keen interest from investors.

Sun Pharmaceutical Industries Ltd shares saw a decrease of -0.01%, reaching a current market price of ₹1,674.60. Investors are evaluating the impact of this decline on the stock's overall performance and attractiveness.

Sun Pharmaceutical Industries Ltd observed a remarkable 0.03% surge in its share price and is presently trading at ₹1,674.85. The increased investor interest is driving this surge.

Sun Pharmaceutical Industries Ltd witnessed a substantial 0.12% increase in its share price and is currently trading at ₹1,674.75. This remarkable performance has caught the eye of investors.

In recent times, Sun Pharmaceutical Industries Ltd witnessed a decline of -0.04% in its share price, and it currently trades at ₹1,672.80 per share. The stock has an ROE of 15.1334% and debt to equity ratio of 0.0327.

With a -0.00% decrease, Sun Pharmaceutical Industries Ltd's share price is currently at ₹1,673.40. This development raises questions about the factors behind the decline. The stock's PE ratio is 36.8100, while the industry PE is 35.3587.

The share price of Sun Pharmaceutical Industries Ltd has plummeted by -0.02%, signalling a challenging period. Currently trading at ₹1,674.40, this stock has caught the eye of bargain hunters, who may be considering their entry points.

The share price of Sun Pharmaceutical Industries Ltd experienced a -0.02% slump and is currently trading at ₹1,674.40. While the stock maintains a PE ratio of 36.8100, the industry PE is 35.3587, raising questions about valuation.

The stock of Sun Pharmaceutical Industries Ltd suffered a -0.02% decline, and it currently trades at ₹1,674.70 per share. Investors are closely monitoring this situation, looking for potential signs of recovery.

The share price of Sun Pharmaceutical Industries Ltd soared by an impressive 0.06%, marking a substantial gain for investors. At present, this stock can be acquired at a current market price of ₹1,674.95 per share.

Sun Pharmaceutical Industries Ltd experienced a -0.15% dip in its share price and is currently trading at ₹1,673.00. The stock has a PE ratio of 36.8100, an ROE of 15.1334% and a debt to equity ratio of 0.0327.

Increased investor interest has propelled Sun Pharmaceutical Industries Ltd's stock to a significant 0.17% gain, with the share price now at ₹1,675.50. Notably, the stock's PE ratio stands at 36.8100, and its Return on Equity (ROE) is 15.1334%.

Sun Pharmaceutical Industries Ltd stock price decreased by -0.07%, with the current market value at ₹1,672.60 per share. Investors are assessing the stock's potential for recovery and future growth prospects.

Following a noteworthy 0.00% increase, Sun Pharmaceutical Industries Ltd's shares are now trading at ₹1,672.75. When it comes to valuation, this stock has a PE ratio of 36.8100, with the industry PE ratio at 35.3587.

Sun Pharmaceutical Industries Ltd has had quite the run lately, experiencing a substantial 0.04% uptick in its share price. As a result, it's now actively trading at ₹1,672.70 per share, making it an attractive option for investors.

Sun Pharmaceutical Industries Ltd's stock has risen by a substantial 0.09%, and as of now, it's trading at ₹1,670.65 per share. This upward trajectory is attracting keen interest from investors.

Climbing steadily, Sun Pharmaceutical Industries Ltd shares have ascended by 0.07%, reaching the current market price of ₹1,669.15. This ascent signifies increased investor sentiment. The stock has an ROE of 15.1334% and debt to equity ratio of 0.0327.

Sun Pharmaceutical Industries Ltd's stock has surged by 0.13%, and it is currently trading at ₹1,668.05. Additionally, the stock maintains a PE ratio of 36.8100, while the industry PE is 35.3587.

Sun Pharmaceutical Industries Ltd's share price has dropped by -0.41%, a development that warrants careful analysis. Presently trading at ₹1,663.50, investors are assessing whether this presents an opportunity or a risk.

In recent times, Sun Pharmaceutical Industries Ltd witnessed a decline of -0.41% in its share price, and it currently trades at ₹1,663.50 per share. The stock has an ROE of 15.1334% and debt to equity ratio of 0.0327.

Sun Pharmaceutical Industries Ltd share price surged by 0.08%. With its current market price standing at ₹1,670.40 per share, this stock is garnering increased attention from the investment community.

The share price of Sun Pharmaceutical Industries Ltd plunged by -0.03%, leaving investors concerned. At this moment, the stock can be acquired at ₹1,669.45, but investors are assessing whether this is a temporary dip or a long-term trend.